NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹489 Cr | ₹346 Cr | ₹401 Cr | ₹216 Cr | ₹82 Cr |
What is the latest Profit Before Tax of NEULAND LABORATORIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹489 Cr |
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹401 Cr |
| Mar2023 | ₹216 Cr |
| Mar2022 | ₹82 Cr |
How is Profit Before Tax of NEULAND LABORATORIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹489 Cr | 41.19 | |
| Mar2025 | ₹346 Cr | -13.73 | |
| Mar2024 | ₹401 Cr | 86.07 | |
| Mar2023 | ₹216 Cr | 162.58 | |
| Mar2022 | ₹82 Cr | - | |
Compare Profit Before Tax of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹30,159.6 Cr | 1.1% | 27.4% | 78.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 1.1% |
27.4% |
78.9% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses